Anthem Blue Cross contract fight could see 22K Sloan Kettering cancer patients lose life-saving treatmentsMemorial Sloan Kettering cancer patients might lose access to critical treatments in 2025 due to contract disputes with Anthem Blue Cross Blue Shield.
Embattled California addiction treatment empire countersues Aetna in $40 million tug-of-warNathan Young defends his treatment practices, arguing Aetna's cost-saving measures jeopardize patient recovery by cutting necessary treatment short.